An estimated 1.5 million women and those assigned female at birth live with endometriosis in the UK, according to Endometriosis UK. Yet the average time from first symptoms to diagnosis remains approximately eight years — a gap that the renewed Women's Health Strategy has identified as a priority for improvement.

Community pharmacists, who are often the first healthcare professional a patient consults about period pain, are in a unique position to recognise potential red flags and signpost patients toward earlier investigation.

What is endometriosis?

Endometriosis is a chronic inflammatory condition in which tissue similar to the lining of the uterus grows outside the uterine cavity — most commonly on the ovaries, fallopian tubes, peritoneum and bowel. The tissue responds to hormonal fluctuations during the menstrual cycle, causing inflammation, adhesions and pain.

The condition affects roughly one in ten women of reproductive age in the UK, though prevalence estimates vary because many cases go undiagnosed.

Red flags in pharmacy period pain consultations

Most women who buy over-the-counter pain relief for period pain have primary dysmenorrhoea — a common, manageable condition. But certain patterns should prompt a pharmacist to recommend a GP appointment rather than simply selling another box of ibuprofen:

No single symptom confirms endometriosis — and pharmacists are not expected to diagnose the condition. The goal is pattern recognition: a customer who returns repeatedly for strong pain relief, whose symptoms are escalating, or who describes pain outside her period deserves a conversation rather than a transaction.

The diagnostic delay problem

According to data from the All-Party Parliamentary Group on Endometriosis, the average diagnostic delay in the UK is 7.5 to 8 years from first symptoms. Multiple factors contribute: normalisation of period pain by patients and clinicians, lack of a simple diagnostic test (definitive diagnosis requires laparoscopy), and symptom overlap with irritable bowel syndrome, interstitial cystitis and other conditions.

The renewed Women's Health Strategy, published by the Department of Health and Social Care in April 2026, explicitly names endometriosis as a condition where earlier recognition and improved pathways are needed. Community pharmacy is not mentioned as a diagnostic setting — nor should it be — but it is acknowledged as a point of first contact that can accelerate referral.

What pharmacists can do

Pharmacy's role in endometriosis sits firmly in the signposting and supportive care space:

During consultations:

• Ask open-ended questions about the pattern of pain, not just its severity. "How long have you been managing this?" and "Does it affect you outside your period?" are more revealing than "How bad is it today?"
• If red flags are present, explain that a GP visit is worthwhile — not because the pain is not real, but because there may be a treatable underlying cause
• Provide information about Endometriosis UK (endometriosis-uk.org), which offers evidence-based patient resources and a helpline

Supporting diagnosed patients:

• Counsel on hormonal treatments (combined pill, progestogens, GnRH analogues) if dispensing them — patients benefit from understanding that these are suppressive rather than curative
• Advise on NSAID timing — taking ibuprofen or naproxen one to two days before the expected onset of pain is more effective than waiting until pain is established
• Be aware that patients on long-term hormonal suppression may present with low mood or other side effects that warrant review

Pain management beyond ibuprofen

For patients awaiting diagnosis or between GP appointments, pharmacists can optimise OTC pain management:

• Ibuprofen 400mg three times daily with food remains first-line for menstrual pain (NICE CKS guidance)
• Naproxen 250mg (available OTC for period pain under certain brand names) offers longer-acting relief
• Paracetamol can be added alongside an NSAID for combination analgesia
• Heat therapy — a 2023 Cochrane review confirmed that topical heat is as effective as ibuprofen for primary dysmenorrhoea and may offer additional benefit when used alongside medication
• TENS machines — some evidence supports transcutaneous electrical nerve stimulation for period pain, though quality of studies is mixed

Codeine-containing products should be used with caution given the chronic, recurring nature of endometriosis pain and the risk of dependence.

The bigger picture

The Women's Health Strategy renewal emphasises that women across the country should be better heard and better served. For endometriosis, "being heard" starts with the first person a woman tells about her pain — and that person is often a pharmacist.

According to PharmSee's data, over 13,000 community pharmacies operate across England, far outnumbering GP surgeries. Every one of those pharmacies is a potential early touchpoint for the estimated 1.5 million women living with endometriosis.

Sources

• Endometriosis UK prevalence data and patient resources
• NICE Clinical Knowledge Summary: Endometriosis
• APPG on Endometriosis: diagnostic delay data
• Department of Health and Social Care, Women's Health Strategy renewal (April 2026)
• PharmSee pharmacy data, accessed April 2026

Explore pharmacy services and job opportunities in your area at PharmSee Jobs and Salary Guide.